Dr. Lee-May Chen, MD

Dr. Chen practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Chen's NPI, 1902861883, was assigned on April 20, 2006. Dr. Chen graduated from University Of Michigan Medical School in 1992. Dr. Chen holds California license G83192.

Dr. Chen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Chen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Chen is also affiliated with UCSF Langley Porter Psychiatric Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Chen to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Chen is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Chen's licenses on file in 2 states: California and Michigan.

Dmand AI lists abdominal adhesion surgery and hysterectomy among the conditions Dr. Chen treats.

CMS data shows 352 Medicare services from Dr. Chen across 6 procedure codes in 2024, for 146 Medicare patients. Medicare paid $28,231 for them.

CMS counts 146 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 73 patients. 67% of them have high blood pressure, and 62% have cancer. 33% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 64, with 97% women.

In 2024, Dr. Chen wrote 137 Medicare Part D claims for 43 patients. 85% of them were for generic drugs. CMS names the drug for 51 of them, across 3 drugs with 11 or more claims each, at $643 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 175 papers to Dr. Chen, published from 2006 to 2025. 2016 was the busiest year, with 14. The most frequent topics are Ovarian Neoplasms, Genital Neoplasms, Female and Endometrial Neoplasms. Dr. Chen has published most often in Gynecol Oncol. Dr. Chen's most frequent co-authors are Jocelyn Susan Chapman, Jon D. Levine, MD and Bruce Cooper, MD.

Dmand AI links Dr. Chen to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Adenocarcinoma, Clear Cell, Carcinoma, Ovarian Epithelial and Ovarian Neoplasms. Open Payments lists research payments to Dr. Chen that name 1 trial.

CMS Open Payments shows 20 general payments to Dr. Chen from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 61% of the total. GlaxoSmithKline, LLC. paid the most, $359. It also lists 29 research payments totaling $4,116 from 2017 to 2019, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Chen, most recently Regional Top Doctor in 2014.

Dr. Chen graduated from University Of Michigan Medical School in 1992. Dr. Chen is a member of American College of Obstetricians and Gynecologists, ACS and ASCO.

Dr. Chen is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.